Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Sheep | 2 | 2018 | 420 | 0.78 | Why? |
| Leukemia Inhibitory Factor | 1 | 2017 | 4 | 0.72 | Why? |
| Women | 1 | 2021 | 159 | 0.72 | Why? |
| Vitrification | 1 | 2017 | 22 | 0.71 | Why? |
| Embryonic Development | 1 | 2017 | 55 | 0.69 | Why? |
| Radiotherapy Planning, Computer-Assisted | 1 | 2018 | 172 | 0.69 | Why? |
| Emtricitabine | 1 | 2018 | 202 | 0.68 | Why? |
| Blastocyst | 1 | 2017 | 65 | 0.66 | Why? |
| Rifampin | 1 | 2018 | 276 | 0.62 | Why? |
| Family Characteristics | 3 | 2021 | 2551 | 0.61 | Why? |
| Anti-HIV Agents | 2 | 2018 | 2209 | 0.59 | Why? |
| Heterocyclic Compounds, 3-Ring | 1 | 2018 | 275 | 0.59 | Why? |
| Radiosurgery | 1 | 2018 | 249 | 0.59 | Why? |
| Darunavir | 1 | 2018 | 477 | 0.56 | Why? |
| Tenofovir | 1 | 2018 | 449 | 0.56 | Why? |
| Reproduction | 1 | 2017 | 259 | 0.55 | Why? |
| Melatonin | 2 | 2018 | 578 | 0.52 | Why? |
| Asymptomatic Infections | 2 | 2021 | 7218 | 0.45 | Why? |
| Brain Neoplasms | 1 | 2018 | 669 | 0.44 | Why? |
| Schools | 3 | 2021 | 4187 | 0.42 | Why? |
| Residence Characteristics | 1 | 2021 | 1927 | 0.40 | Why? |
| Hospitals, Teaching | 1 | 2018 | 1609 | 0.40 | Why? |
| Estrus | 2 | 2018 | 2 | 0.38 | Why? |
| Communicable Disease Control | 4 | 2021 | 29620 | 0.35 | Why? |
| Antioxidants | 1 | 2017 | 1593 | 0.34 | Why? |
| Anti-Infective Agents | 1 | 2019 | 1766 | 0.33 | Why? |
| Leadership | 1 | 2021 | 2241 | 0.33 | Why? |
| Socioeconomic Factors | 2 | 2021 | 8495 | 0.32 | Why? |
| Community-Acquired Infections | 1 | 2019 | 2328 | 0.32 | Why? |
| Seasons | 2 | 2018 | 4071 | 0.30 | Why? |
| HIV Infections | 3 | 2021 | 11620 | 0.27 | Why? |
| Tuberculosis | 1 | 2018 | 2895 | 0.23 | Why? |
| Masks | 2 | 2021 | 8528 | 0.22 | Why? |
| Social Isolation | 1 | 2021 | 5932 | 0.21 | Why? |
| Sex Ratio | 1 | 2021 | 69 | 0.21 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.20 | Why? |
| Basic Reproduction Number | 2 | 2021 | 2676 | 0.19 | Why? |
| Anestrus | 1 | 2018 | 1 | 0.19 | Why? |
| Pneumonia | 1 | 2019 | 5652 | 0.19 | Why? |
| Progestins | 1 | 2018 | 43 | 0.19 | Why? |
| Fertility Agents | 1 | 2017 | 4 | 0.18 | Why? |
| Embryo Culture Techniques | 1 | 2017 | 11 | 0.18 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.18 | Why? |
| Drug Implants | 1 | 2017 | 43 | 0.18 | Why? |
| AIDS-Related Opportunistic Infections | 1 | 2020 | 260 | 0.17 | Why? |
| United Kingdom | 5 | 2021 | 18046 | 0.17 | Why? |
| Sexism | 1 | 2021 | 278 | 0.16 | Why? |
| Microbiology | 1 | 2019 | 134 | 0.16 | Why? |
| Radiotherapy Dosage | 1 | 2018 | 428 | 0.16 | Why? |
| Oxazines | 1 | 2018 | 279 | 0.16 | Why? |
| Mandatory Programs | 1 | 2021 | 291 | 0.16 | Why? |
| Doxycycline | 1 | 2019 | 307 | 0.16 | Why? |
| Pneumonia, Pneumocystis | 1 | 2020 | 322 | 0.15 | Why? |
| Infectious Disease Medicine | 1 | 2019 | 311 | 0.15 | Why? |
| Occupations | 1 | 2021 | 733 | 0.15 | Why? |
| Humans | 27 | 2021 | 930598 | 0.15 | Why? |
| Piperazines | 1 | 2018 | 445 | 0.14 | Why? |
| Culture Media | 1 | 2017 | 366 | 0.14 | Why? |
| Specialization | 1 | 2019 | 432 | 0.14 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2018 | 801 | 0.14 | Why? |
| Publications | 1 | 2020 | 463 | 0.14 | Why? |
| Psychosocial Support Systems | 1 | 2021 | 710 | 0.14 | Why? |
| Drug Therapy, Combination | 2 | 2018 | 7268 | 0.14 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2018 | 782 | 0.13 | Why? |
| Cryopreservation | 1 | 2017 | 464 | 0.13 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.13 | Why? |
| Policy | 1 | 2021 | 1372 | 0.13 | Why? |
| Mentoring | 1 | 2019 | 432 | 0.12 | Why? |
| Cattle | 1 | 2017 | 1336 | 0.12 | Why? |
| Pyridones | 1 | 2018 | 738 | 0.12 | Why? |
| Testis | 1 | 2017 | 566 | 0.12 | Why? |
| Cell Survival | 1 | 2017 | 1581 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Contact Tracing | 2 | 2021 | 8448 | 0.11 | Why? |
| Minority Groups | 1 | 2021 | 1631 | 0.10 | Why? |
| Research Personnel | 1 | 2021 | 1037 | 0.10 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.10 | Why? |
| Coronavirus Infections | 5 | 2021 | 253789 | 0.09 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2021 | 3444 | 0.09 | Why? |
| Racism | 1 | 2021 | 1462 | 0.09 | Why? |
| Epidemiological Monitoring | 1 | 2021 | 3493 | 0.09 | Why? |
| Disease Susceptibility | 1 | 2021 | 4002 | 0.08 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.08 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Vulnerable Populations | 1 | 2021 | 3099 | 0.08 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.08 | Why? |
| Databases, Factual | 1 | 2021 | 6248 | 0.07 | Why? |
| Research Design | 1 | 2021 | 5830 | 0.07 | Why? |
| Communicable Diseases | 1 | 2019 | 2148 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.07 | Why? |
| Health Status Disparities | 1 | 2021 | 4072 | 0.06 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.06 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.06 | Why? |
| Breast Neoplasms | 1 | 2021 | 3633 | 0.06 | Why? |
| Education, Medical | 1 | 2019 | 2461 | 0.06 | Why? |
| Occupational Exposure | 1 | 2021 | 4742 | 0.06 | Why? |
| Travel | 1 | 2021 | 7220 | 0.06 | Why? |
| Male | 8 | 2021 | 367725 | 0.06 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.05 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Health Policy | 1 | 2021 | 6242 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2021 | 6166 | 0.05 | Why? |
| Animals | 3 | 2018 | 78931 | 0.05 | Why? |
| Women, Working | 1 | 2020 | 96 | 0.05 | Why? |
| Social Welfare | 1 | 2020 | 141 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.05 | Why? |
| Pneumocystis carinii | 1 | 2020 | 205 | 0.05 | Why? |
| Ghana | 1 | 2021 | 763 | 0.04 | Why? |
| Progesterone | 1 | 2018 | 106 | 0.04 | Why? |
| Adult | 6 | 2021 | 244371 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.04 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.04 | Why? |
| Norway | 1 | 2021 | 1004 | 0.04 | Why? |
| Russia | 1 | 2021 | 989 | 0.04 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.04 | Why? |
| School Teachers | 1 | 2020 | 345 | 0.04 | Why? |
| Colombia | 1 | 2021 | 1241 | 0.04 | Why? |
| Bias | 1 | 2021 | 1109 | 0.04 | Why? |
| Editorial Policies | 1 | 2020 | 408 | 0.04 | Why? |
| Environment | 1 | 2021 | 769 | 0.04 | Why? |
| Child | 2 | 2021 | 70012 | 0.03 | Why? |
| HIV | 1 | 2021 | 1116 | 0.03 | Why? |
| Female | 6 | 2021 | 380317 | 0.03 | Why? |
| Awareness | 1 | 2019 | 529 | 0.03 | Why? |
| Fertility | 1 | 2018 | 367 | 0.03 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2021 | 1887 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.03 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Europe | 2 | 2019 | 12702 | 0.03 | Why? |
| Schools, Medical | 1 | 2019 | 793 | 0.03 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.03 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.03 | Why? |
| South Africa | 1 | 2021 | 3326 | 0.03 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.02 | Why? |
| World Health Organization | 1 | 2021 | 4213 | 0.02 | Why? |
| Periodicals as Topic | 1 | 2020 | 1492 | 0.02 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Internationality | 1 | 2019 | 3297 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Curriculum | 1 | 2019 | 3083 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Aged | 1 | 2021 | 215776 | 0.02 | Why? |
| Students, Medical | 1 | 2019 | 4032 | 0.01 | Why? |
| Physicians | 1 | 2019 | 4214 | 0.01 | Why? |
| Italy | 1 | 2021 | 38444 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2019 | 43792 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2019 | 53120 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
Cevik's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(163)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(128)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_